Evidence map›Paper›PMID 36921242›Full record

ArticleJCO global oncology2023

Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics.

Adedayo Joseph, Abdul R Shour, Nwamaka N Lasebikan, Mutiu A Jimoh, Bolanle C Adegboyega, Emmanuella Nwachukwu, Opeyemi Awofeso, Azeezat Ajose, Abiola Ibraheem, Omolara Aminat Fatiregun and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 2 countries.

Adedayo JosephNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria.ORCID 0000-0002-7938-1218
Abdul R ShourCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI.
Nwamaka N LasebikanUniversity of Nigeria Teaching Hospital, Enugu, Nigeria.ORCID 0000-0002-3775-0492
Mutiu A JimohUniversity College Hospital, Ibadan, Nigeria.ORCID 0000-0002-6383-3961
Bolanle C AdegboyegaNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria.ORCID 0000-0001-5208-8073
Emmanuella NwachukwuNational Hospital, Abuja, Nigeria.
Opeyemi AwofesoHarvard Medical School, Boston, MA.ORCID 0000-0002-6233-4642
Azeezat AjoseHarvard Medical School, Boston, MA.ORCID 0000-0002-4491-1805
Abiola IbraheemDivision of Hematology & Oncology, University of Illinois College of Medicine, Chicago, IL.ORCID 0000-0002-6593-7908
Omolara Aminat FatiregunLagos State University Teaching Hospital (LASUTH), Lagos, Nigeria.ORCID 0000-0001-9219-9069
Musa Ali-GombeFederal Teaching Hospital, Gombe, Nigeria.ORCID 0000-0002-4431-7777
Usman M AliyuUsman Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Abdallah Elsaid KotkatNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria.
Olusegun Abayomi Biyi-OlutundeUniversity of Port-Harcourt Teaching Hospital, Rivers State, Nigeria.
Evaristus Oseiwe ObohUniversity of Benin Teaching Hospital, Edo, Nigeria.ORCID 0000-0003-2636-1333
Ismail H ZubairuAhmadu Bello University Teaching Hospital, Kaduna, Nigeria.ORCID 0000-0002-3661-3250
Mohammad Rifat HaiderCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI.ORCID 0000-0002-0690-8242
Bankole OlatosiMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI.ORCID 0000-0002-8295-8735
David PuthoffMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI.ORCID 0000-0003-1583-9864
Adedayo A OnitiloCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WI.ORCID 0000-0001-9185-0606
Marshfield Clinic · USLagos University Teaching Hospital · NGHarvard University · USAhmadu Bello University Teaching Hospital · NGFederal Medical Centre · NGLagos State University Teaching Hospital · NGNational Hospital Abuja · NGUniversity College Hospital, Ibadan · NGUniversity of Benin Teaching Hospital · NGUniversity of Illinois Urbana-Champaign · USUniversity of Nigeria Teaching Hospital · NGUniversity of Port Harcourt Teaching Hospital · NGUsmanu Danfodiyo University Teaching Hospital, Sokoto · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.

methodsData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as patients who reported their routine follow-up visits were converted to virtual visits because of COVID-19 (coded yes/no). Covariates included patient age, ethnicity, marital status, income, cancer treatment, service disruption, and cancer diagnosis/type. Stata/SE.v.17 (StataCorp, College Station, TX) was used to perform chi-square and logistic regression analyses.

resultsThe majority of the 1,097 patients with cancer were female (65.7%) and age 55 years and older (35.0%). Because of COVID-19, 12.6% of patients' routine follow-ups were converted to virtual visits. More patients who canceled/postponed surgery (17.7%

conclusionCOVID-19 caused many patients with cancer in Nigeria to convert visits to a virtual format. These conversions were more common in patients whose surgery, radiotherapy, chemotherapy, and injection chemotherapy treatments were canceled or postponed. Our findings suggest how COVID-19 affects cancer treatment services and the importance of collecting teleoncological care data in Nigeria.

Indexed as

COVID-19NeoplasmsAmbulatory Care FacilitiesEthnicityFemaleHumansMaleMiddle AgedOutpatients

Identifiers

PMID36921242
PMCPMC10497253
OpenAlexW4324332742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.